men have increased health risks due to biological and social factors. Research in the area of men's health has been focused on disease events and subsequent disabilities. In future aging societies, more attention should be paid to the importance of men's health because a decreased quality of life and increased social burden are impending unless proper maneuvers are taken to slow the development and progression of morbidity through the use of preventive strategies. The adoption of a healthier lifestyle and the early identification and management of risk factors are very important and can be an initiative for prevention and for slowing the progression of morbidities with related quality of life issues. Males are rather vulnerable in terms of health, and conscious and active efforts are required to promote their health in an aging society. Here, we hope to shed light on the influence of lifestyle modifications and their clinical implications on men's health.]]>
Aging ; Hope ; Humans ; Life Style ; Male ; Men's Health ; Quality of Life ; Risk Factors ; Testosterone

Metabolic syndrome (MetS) represents a cluster of conditions that have a negative impact on human health overall. Its prevalence has been rapidly increasing worldwide and has coincided with a global decrease in birth rates and fertility potential. This review aims to address this observation through studying the relationship between MetS and male reproductive health. The effects of obesity, dyslipidemia, hypertension, and insulin resistance on male fertility were examined and supporting evidence explaining the pathophysiology of sperm dysfunction with each MetS component were described. Adopting a healthy lifestyle appears to be the single most important intervention to prevent the unwanted effects of MetS on men's health and fertility. Further studies addressing the components of MetS and their impact on male reproduction are required to enhance our understanding of the underlying pathophysiology and to propose new methods for therapeutic intervention.
Birth Rate ; Dyslipidemias ; Fertility ; Glucose Intolerance ; Humans ; Hypertension ; Infertility, Male ; Insulin Resistance ; Life Style ; Male ; Men's Health ; Obesity ; Prevalence ; Reproduction ; Reproductive Health ; Spermatozoa

OBJECTIVE: This cross-sectional study aimed to investigate the association between rheumatoid factor (RF) positivity and bone mineral density (BMD) in male Korean subjects without any history of joint disease. METHODS: Of 84,344 males who had undergone a comprehensive health checkup program in 2012, 1,390 male health examinees were recruited, whose BMD and RF results were available. A RF titer ≥20 IU/mL was considered positive. BMD was measured at lumbar spine (L1~L4) or hip (femoral neck and total hip) by dual-energy X-ray absorptiometry. RESULTS: The association between RF positivity and BMD was assessed by multiple linear regression analysis. The mean age was 52.7±10.9 years (range 19~88 years), and RF was detected in 64 subjects (4.6%). Demographics and laboratory data were not different between RF-positive and -negative subjects except hepatitis B surface antigen (HBsAg), which was more frequently seen in RF-positive subjects (15.6% vs. 4.3%, p=0.001). RF-positive subjects had significantly lower BMD compared to RF-negative subjects in lumbar spine but not in total hip regardless of the existence of HBsAg (1.17±0.16 g/cm2 vs. 1.10±0.18 g/cm2, p=0.002 in total subjects; 1.17±0.16 g/cm2 vs. 1.10±0.18 g/cm2, p=0.004 in HBsAg-negative subjects). After adjusting for multiple confounders, RF positivity was negatively associated with lumbar spine BMD (B=−0.088 and standard error=0.035, p=0.011). CONCLUSION: Our results show that the presence of RF could have an unfavorable impact on bone density in apparently normal males. Additional studies to elucidate the osteoimmunological mechanism of rheumatoid factor are warranted.
Absorptiometry, Photon ; Arthritis* ; Bone Density ; Cross-Sectional Studies ; Demography ; Hepatitis B Surface Antigens ; Hip ; Humans ; Joint Diseases ; Linear Models ; Male* ; Men's Health ; Neck ; Rheumatoid Factor* ; Spine

No abstract available.
Animals ; Humans ; Male ; Men's Health ; Prostatitis ; Rats

No abstract available.
Men's Health

No abstract available.
Aging* ; Men's Health*

No abstract available.
Men's Health*

No abstract available.
Men's Health*

Laryngeal SCCA usually presents with hoarseness when the glottis is involved, dysphagia if the supraglottis is involved, and difficulty of breathing and stridor in subglottic invovlement. A neck mass as an initial presentation of laryngeal carcinoma is commonly linked to the involvement of the supraglottis due to its rich lymphatic drainage. About 70% of supraglottic tumours present with advanced disease (stages III-IV),1 while 75% of glottic tumours present with localized disease (stages I-II).1 Smoking and alcohol consumption are considered highly significant etiologic factors but evidence has suggested a possible role for human papilloma virus (HPV) infection, ras oncogene activation, and gastroesophageal reflux as well.2 To the best of our knowledge, laryngeal squamous cell carcinoma has not been associated with herpes simplex virus (HSV). We report a case of laryngeal squamous cell carcinoma with an unusual presentation and peculiar histopathology, and discuss its potential association with herpes simplex virus.
Human ; Male ; Aged ; Carcinoma ; Larynx ; Glottis ; Men ; Simplexvirus

OBJECTIVES: This research aims to study the effect of omega-3 fatty acid as an adjunct to pharmacologic treatment for major depressive disorder occurring in-out patients aged 18-65 years old in a private tertiary hospital of Metro Manila who will receive pharmacologic maintenance antidepressant therapy. With the knowledge that this is a pilot study for Filipinos, the endpoint will be geared towards determining the feasibility of actually prescribing a dietary supplement in the form of omega-3 to further improve the depressive condition of our patients.
METHODOLOGY: Patients with a current diagnosis of major depressive disorder, based on Hamilton Depression Rating Scale score of 14-18 or more, which is considered as moderate depression were observed for 4 weeks. The study design was a 4-week, double-blind addition of omega-3 or placebo to ongoing antidepressant therapy. Patients were required to continue their current antidepressant treatment at the same dose they were receiving when they entered the study. Patients were required to continue their current antidepressant treatment at the same dose they were receiving when they entered the study. Patients who were included in the study had been receiving their antidepressant medication for at least three weeks at the therapeutic dose.
RESULTS: Twenty-four patients participated. Eighteen were women, and six were men. Their mean age was 39.7 (range=18-63). The mean reduction of HAM-D scale score in patients taking omega-3 was 12.17 points, compared with 9.58 in patients receiving placebo.
CONCLUSION: This comparison in the reduction of scores was insignificant. There was no observable significant trends toward the superiority of omega-3 supplements over placebo in reducing depressive symptoms.

Human ; Male ; Female ; Middle Aged ; Adult ; Young Adult ; Adolescent ; Fatty Acids ; Depressive Disorder ; Women ; Men ; Lipids